Heating-mediated purification of active FGF21 and structure-based design of its variant with enhanced potency
Abstract Fibroblast growth factor 21 (FGF21) has pharmaceutical potential against obesity-related metabolic disorders, including non-alcoholic fatty liver disease. Since thermal stability is a desirable factor for therapeutic proteins, we investigated the thermal behavior of human FGF21. FGF21 remai...
Main Authors: | Ye-Eun Jung, Kyeong Won Lee, Jae Hyun Cho, Da-Woon Bae, Bo-Gyeong Jeong, Yeon-Ju Jung, Soo-Bong Park, Young Jun An, Kyungchan Kim, Ga Seul Lee, Lin-Woo Kang, Jeong Hee Moon, Jung-Hyun Lee, Eun-Kyoung Kim, Hyung-Soon Yim, Sun-Shin Cha |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-01-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-27717-x |
Similar Items
-
FGF11 influences 3T3‐L1 preadipocyte differentiation by modulating the expression of PPARγ regulators
by: Kyeong Won Lee, et al.
Published: (2019-04-01) -
Silencing of hypothalamic FGF11 prevents diet-induced obesity
by: Jae Hyun Cho, et al.
Published: (2022-09-01) -
Eclipta prostrata promotes the induction of anagen, sustains the anagen phase through regulation of FGF-7 and FGF-5
by: Keun-Hyeun Lee, et al.
Published: (2019-01-01) -
Crystal structure of AmpC BER and molecular docking lead to the discovery of broad inhibition activities of halisulfates against β-lactamases
by: Bo-Gyeong Jeong, et al.
Published: (2021-01-01) -
Paeonol oxime inhibits bFGF-induced angiogenesis and reduces VEGF levels in fibrosarcoma cells.
by: Hyo-Jeong Lee, et al.
Published: (2010-01-01)